COVID-19 antibody titers after tixagevimab–cilgavimab injection in patients with hematologic diseases; a single-center, prospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19 antibody titers after tixagevimab–cilgavimab injection in patients with hematologic diseases; a single-center, prospective study

Published:2024-04-16 Issue:8 Volume:65 Page:1117-1126
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Nakamura Naokazu¹²^ORCID,Tsunemine Hiroko¹,Ikunari Ryo¹,Sakai Tomomi¹³,Arima Nobuyoshi¹

Affiliation:

1. Department of Hematology, Shinko Hospital, Kobe, Japan

2. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

3. Department of Hematology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2343519

Reference45 articles.

1. World Health Organization WHO coronavirus 2019 (COVID-19) pandemic. Available at. 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

2. Johns Hopkins University and Medicine Coronavirus Resource Center. Available at. https://coronavirus.jhu.edu. Accessed August 21 2021.

3. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

4. Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom

5. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP